• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Comprehensive Overview of 4-Bromoisoquinolin-1-amine (CAS No. 55270-27-4): Properties, Applications, and Research Insights

4-Bromoisoquinolin-1-amine (CAS No. 55270-27-4) is a specialized organic compound belonging to the isoquinoline family, characterized by the presence of a bromine substituent at the 4-position and an amino group at the 1-position. This heterocyclic structure renders it a valuable intermediate in pharmaceutical and agrochemical research. The compound's molecular formula, C₉H₇BrN₂, and its distinct brominated isoquinoline backbone contribute to its reactivity and versatility in synthetic chemistry.

In recent years, 4-Bromoisoquinolin-1-amine has garnered attention due to its potential role in the development of novel therapeutic agents. Researchers are particularly interested in its application as a building block for small-molecule inhibitors targeting enzymes like kinases, which are pivotal in cancer and inflammatory diseases. The compound's bromine atom offers a strategic handle for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, making it a sought-after reagent in medicinal chemistry.

From an industrial perspective, the demand for high-purity 4-Bromoisoquinolin-1-amine has risen alongside advancements in high-throughput screening (HTS) technologies. Laboratories frequently inquire about its stability under varying pH conditions, solubility profiles in organic solvents, and compatibility with automated synthesis platforms. These queries reflect the compound's integration into modern drug discovery workflows, where reproducibility and scalability are critical.

Environmental and safety considerations are also prominent in discussions about 55270-27-4. While not classified as hazardous under standard regulations, proper handling protocols—such as the use of personal protective equipment (PPE) and adherence to green chemistry principles—are emphasized to minimize risks during large-scale production. This aligns with the broader industry shift toward sustainable synthetic methodologies.

Analytical techniques like HPLC, NMR spectroscopy, and mass spectrometry are routinely employed to verify the purity and structural integrity of 4-Bromoisoquinolin-1-amine. Suppliers often highlight batch-to-batch consistency, as impurities can significantly impact downstream applications. For instance, trace metals may interfere with catalytic reactions, underscoring the need for rigorous quality control.

Emerging trends in AI-driven drug design have further amplified interest in this compound. Computational models frequently utilize brominated heterocycles like 4-Bromoisoquinolin-1-amine to predict binding affinities or optimize lead compounds. This intersection of synthetic chemistry and machine learning exemplifies how traditional intermediates are adapting to cutting-edge research paradigms.

In summary, 4-Bromoisoquinolin-1-amine (CAS No. 55270-27-4) exemplifies the synergy between structural specificity and functional adaptability. Its role in drug discovery, coupled with its compatibility with sustainable practices, positions it as a cornerstone in contemporary organic synthesis. Future studies may explore its utility in photopharmacology or as a template for bioconjugation, reflecting the dynamic evolution of chemical research.

• 35486-42-1(2-Amino-3,5-dibromopyridine)
• 215453-26-2(6-Bromoisoquinolin-1-amine)
• 959558-28-2(4-Bromo-2,7-naphthyridin-1-amine)
• 76942-20-6(2,6-Diamine-3,5-Dibromopyridine)
• 10321-49-0(4-Bromoisoquinolin-3-amine)
• 891785-28-7(6-bromoisoquinolin-3-amine)
• 1072-97-5(5-bromopyridin-2-amine)
• 27187-06-0(4-bromo-1-hydrazinoisoquinoline)
• 852570-80-0(5-Bromoisoquinolin-1-amine)
• 215453-53-5(7-Bromoisoquinolin-1-amine)